Fatal breakthrough mucormycosis in a multivisceral transplant patient receiving micafungin
John R Louis-Auguste,
Christianne Micallef,
Tim Ambrose,
Sara Upponi,
Andrew J Butler,
Dunecan Massey,
Stephen J Middleton,
Neil Russell,
Charlotte S Rutter,
Lisa M Sharkey,
Jeremy Woodward,
Effrossyni Gkrania-Klotsas,
David A Enoch
Jul 24, 2019
INTRODUCTION: Antifungal agents are routinely used in the post-transplant setting for both prophylaxis and treatment of presumed and proven fungal infections. Micafungin is an echinocandin-class antifungal with broad antifungal...